Sponsor pipeline

Novartis Gene Therapies clinical trial pipeline

Get alerts when Novartis Gene Therapies's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04042025 Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Spinal Muscular Atrophy Type I Active, Not Recruiting 2026-09-24
Not specified
NCT03421977 Long-Term Follow-up Study for Patients From AVXS-101-CL-101 Spinal Muscular Atrophy 1 Active, Not Recruiting 2026-09-22

Disease areas by active trials

Spinal Muscular Atrophy (2)

Get alerts when Novartis Gene Therapies's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free